Generic Drugs Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription
1.2.3 Non-Prescription Drugs
1.3 Market by Application
1.3.1 Global Generic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2016-2027)
2.2 Generic Drugs Growth Trends by Regions
2.2.1 Generic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Generic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Generic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Generic Drugs Industry Dynamic
2.3.1 Generic Drugs Market Trends
2.3.2 Generic Drugs Market Drivers
2.3.3 Generic Drugs Market Challenges
2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drugs Players by Revenue
3.1.1 Global Top Generic Drugs Players by Revenue (2016-2021)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Generic Drugs Revenue
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2020
3.5 Generic Drugs Key Players Head office and Area Served
3.6 Key Players Generic Drugs Product Solution and Service
3.7 Date of Enter into Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Generic Drugs Forecasted Market Size by Type (2022-2027)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Generic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Generic Drugs Market Size (2016-2027)
6.2 North America Generic Drugs Market Size by Type
6.2.1 North America Generic Drugs Market Size by Type (2016-2021)
6.2.2 North America Generic Drugs Market Size by Type (2022-2027)
6.2.3 North America Generic Drugs Market Size by Type (2016-2027)
6.3 North America Generic Drugs Market Size by Application
6.3.1 North America Generic Drugs Market Size by Application (2016-2021)
6.3.2 North America Generic Drugs Market Size by Application (2022-2027)
6.3.3 North America Generic Drugs Market Size by Application (2016-2027)
6.4 North America Generic Drugs Market Size by Country
6.4.1 North America Generic Drugs Market Size by Country (2016-2021)
6.4.2 North America Generic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Generic Drugs Market Size (2016-2027)
7.2 Europe Generic Drugs Market Size by Type
7.2.1 Europe Generic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Generic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Generic Drugs Market Size by Type (2016-2027)
7.3 Europe Generic Drugs Market Size by Application
7.3.1 Europe Generic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Generic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Generic Drugs Market Size by Application (2016-2027)
7.4 Europe Generic Drugs Market Size by Country
7.4.1 Europe Generic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Generic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Generic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Generic Drugs Market Size by Type
8.2.1 Asia-Pacific Generic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Generic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Generic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Generic Drugs Market Size by Application
8.3.1 Asia-Pacific Generic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Generic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Generic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Generic Drugs Market Size by Region
8.4.1 Asia-Pacific Generic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Generic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Drugs Market Size (2016-2027)
9.2 Latin America Generic Drugs Market Size by Type
9.2.1 Latin America Generic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Generic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Generic Drugs Market Size by Type (2016-2027)
9.3 Latin America Generic Drugs Market Size by Application
9.3.1 Latin America Generic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Generic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Generic Drugs Market Size by Application (2016-2027)
9.4 Latin America Generic Drugs Market Size by Country
9.4.1 Latin America Generic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Generic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Generic Drugs Market Size by Type
10.2.1 Middle East & Africa Generic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Generic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Generic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Generic Drugs Market Size by Application
10.3.1 Middle East & Africa Generic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Generic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Generic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Generic Drugs Market Size by Country
10.4.1 Middle East & Africa Generic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Generic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Generic Drugs Introduction
11.1.4 Teva Revenue in Generic Drugs Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Details
11.2.2 Novartis - Sandoz Business Overview
11.2.3 Novartis - Sandoz Generic Drugs Introduction
11.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2016-2021)
11.2.5 Novartis - Sandoz Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Generic Drugs Introduction
11.3.4 Mylan Revenue in Generic Drugs Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen
11.5.1 Aspen Company Details
11.5.2 Aspen Business Overview
11.5.3 Aspen Generic Drugs Introduction
11.5.4 Aspen Revenue in Generic Drugs Business (2016-2021)
11.5.5 Aspen Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Drugs Introduction
11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Details
11.7.2 Pfizer (Hospira) Business Overview
11.7.3 Pfizer (Hospira) Generic Drugs Introduction
11.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2016-2021)
11.7.5 Pfizer (Hospira) Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Generic Drugs Introduction
11.8.4 Sanofi Revenue in Generic Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Aurobindo
11.9.1 Aurobindo Company Details
11.9.2 Aurobindo Business Overview
11.9.3 Aurobindo Generic Drugs Introduction
11.9.4 Aurobindo Revenue in Generic Drugs Business (2016-2021)
11.9.5 Aurobindo Recent Development
11.10 Lupin
11.10.1 Lupin Company Details
11.10.2 Lupin Business Overview
11.10.3 Lupin Generic Drugs Introduction
11.10.4 Lupin Revenue in Generic Drugs Business (2016-2021)
11.10.5 Lupin Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Details
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Generic Drugs Introduction
11.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2016-2021)
11.11.5 Dr. Reddy's Recent Development
11.12 Apotex
11.12.1 Apotex Company Details
11.12.2 Apotex Business Overview
11.12.3 Apotex Generic Drugs Introduction
11.12.4 Apotex Revenue in Generic Drugs Business (2016-2021)
11.12.5 Apotex Recent Development
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Generic Drugs Introduction
11.13.4 Cipla Revenue in Generic Drugs Business (2016-2021)
11.13.5 Cipla Recent Development
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Details
11.14.2 ENDO (Par Pharmaceutical) Business Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction
11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2016-2021)
11.14.5 ENDO (Par Pharmaceutical) Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Generic Drugs Introduction
11.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2016-2021)
11.15.5 Stada Arzneimittel Recent Development
11.16 Krka Group
11.16.1 Krka Group Company Details
11.16.2 Krka Group Business Overview
11.16.3 Krka Group Generic Drugs Introduction
11.16.4 Krka Group Revenue in Generic Drugs Business (2016-2021)
11.16.5 Krka Group Recent Development
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Details
11.17.2 Nichi-Iko Pharmaceutical Business Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction
11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.17.5 Nichi-Iko Pharmaceutical Recent Development
11.18 Valeant
11.18.1 Valeant Company Details
11.18.2 Valeant Business Overview
11.18.3 Valeant Generic Drugs Introduction
11.18.4 Valeant Revenue in Generic Drugs Business (2016-2021)
11.18.5 Valeant Recent Development
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Details
11.19.2 Zydus Cadila Business Overview
11.19.3 Zydus Cadila Generic Drugs Introduction
11.19.4 Zydus Cadila Revenue in Generic Drugs Business (2016-2021)
11.19.5 Zydus Cadila Recent Development
11.20 Hikma
11.20.1 Hikma Company Details
11.20.2 Hikma Business Overview
11.20.3 Hikma Generic Drugs Introduction
11.20.4 Hikma Revenue in Generic Drugs Business (2016-2021)
11.20.5 Hikma Recent Development
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Details
11.21.2 Pharmaniaga Berhad Business Overview
11.21.3 Pharmaniaga Berhad Generic Drugs Introduction
11.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2016-2021)
11.21.5 Pharmaniaga Berhad Recent Development
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Details
11.22.2 Hovid Berhad Business Overview
11.22.3 Hovid Berhad Generic Drugs Introduction
11.22.4 Hovid Berhad Revenue in Generic Drugs Business (2016-2021)
11.22.5 Hovid Berhad Recent Development
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Details
11.23.2 Duopharma Biotech Business Overview
11.23.3 Duopharma Biotech Generic Drugs Introduction
11.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2016-2021)
11.23.5 Duopharma Biotech Recent Development
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Details
11.24.2 Kotra Pharma Business Overview
11.24.3 Kotra Pharma Generic Drugs Introduction
11.24.4 Kotra Pharma Revenue in Generic Drugs Business (2016-2021)
11.24.5 Kotra Pharma Recent Development
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Details
11.25.2 HOE Pharmaceutical Business Overview
11.25.3 HOE Pharmaceutical Generic Drugs Introduction
11.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.25.5 HOE Pharmaceutical Recent Development
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Details
11.26.2 Y.S.P. Industries Business Overview
11.26.3 Y.S.P. Industries Generic Drugs Introduction
11.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2016-2021)
11.26.5 Y.S.P. Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription
Table 3. Key Players of Non-Prescription Drugs
Table 4. Global Generic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Generic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Generic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Generic Drugs Market Share by Regions (2016-2021)
Table 8. Global Generic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Generic Drugs Market Share by Regions (2022-2027)
Table 10. Generic Drugs Market Trends
Table 11. Generic Drugs Market Drivers
Table 12. Generic Drugs Market Challenges
Table 13. Generic Drugs Market Restraints
Table 14. Global Generic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Generic Drugs Market Share by Players (2016-2021)
Table 16. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2020)
Table 17. Ranking of Global Top Generic Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Drugs Product Solution and Service
Table 21. Date of Enter into Generic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Generic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Generic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Generic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Generic Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Generic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Generic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Generic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Generic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Generic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Generic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Generic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Generic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Generic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Generic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Teva Company Details
Table 62. Teva Business Overview
Table 63. Teva Generic Drugs Product
Table 64. Teva Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 65. Teva Recent Development
Table 66. Novartis - Sandoz Company Details
Table 67. Novartis - Sandoz Business Overview
Table 68. Novartis - Sandoz Generic Drugs Product
Table 69. Novartis - Sandoz Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 70. Novartis - Sandoz Recent Development
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Generic Drugs Product
Table 74. Mylan Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Sun Pharmaceutical Company Details
Table 77. Sun Pharmaceutical Business Overview
Table 78. Sun Pharmaceutical Generic Drugs Product
Table 79. Sun Pharmaceutical Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 80. Sun Pharmaceutical Recent Development
Table 81. Aspen Company Details
Table 82. Aspen Business Overview
Table 83. Aspen Generic Drugs Product
Table 84. Aspen Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 85. Aspen Recent Development
Table 86. Fresenius Kabi Company Details
Table 87. Fresenius Kabi Business Overview
Table 88. Fresenius Kabi Generic Drugs Product
Table 89. Fresenius Kabi Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 90. Fresenius Kabi Recent Development
Table 91. Pfizer (Hospira) Company Details
Table 92. Pfizer (Hospira) Business Overview
Table 93. Pfizer (Hospira) Generic Drugs Product
Table 94. Pfizer (Hospira) Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 95. Pfizer (Hospira) Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Aurobindo Company Details
Table 101. Aurobindo Business Overview
Table 102. Aurobindo Generic Drugs Product
Table 103. Aurobindo Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 104. Aurobindo Recent Development
Table 105. Lupin Company Details
Table 106. Lupin Business Overview
Table 107. Lupin Generic Drugs Product
Table 108. Lupin Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 109. Lupin Recent Development
Table 110. Dr. Reddy's Company Details
Table 111. Dr. Reddy's Business Overview
Table 112. Dr. Reddy's Generic Drugs Product
Table 113. Dr. Reddy's Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 114. Dr. Reddy's Recent Development
Table 115. Apotex Company Details
Table 116. Apotex Business Overview
Table 117. Apotex Generic Drugs Product
Table 118. Apotex Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 119. Apotex Recent Development
Table 120. Cipla Company Details
Table 121. Cipla Business Overview
Table 122. Cipla Generic Drugs Product
Table 123. Cipla Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 124. Cipla Recent Development
Table 125. ENDO (Par Pharmaceutical) Company Details
Table 126. ENDO (Par Pharmaceutical) Business Overview
Table 127. ENDO (Par Pharmaceutical) Generic Drugs Product
Table 128. ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 129. ENDO (Par Pharmaceutical) Recent Development
Table 130. Stada Arzneimittel Company Details
Table 131. Stada Arzneimittel Business Overview
Table 132. Stada Arzneimittel Generic Drugs Product
Table 133. Stada Arzneimittel Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 134. Stada Arzneimittel Recent Development
Table 135. Krka Group Company Details
Table 136. Krka Group Business Overview
Table 137. Krka Group Generic Drugs Product
Table 138. Krka Group Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 139. Krka Group Recent Development
Table 140. Nichi-Iko Pharmaceutical Company Details
Table 141. Nichi-Iko Pharmaceutical Business Overview
Table 142. Nichi-Iko Pharmaceutical Generic Drugs Product
Table 143. Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 144. Nichi-Iko Pharmaceutical Recent Development
Table 145. Valeant Company Details
Table 146. Valeant Business Overview
Table 147. Valeant Generic Drugs Product
Table 148. Valeant Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 149. Valeant Recent Development
Table 150. Zydus Cadila Company Details
Table 151. Zydus Cadila Business Overview
Table 152. Zydus Cadila Generic Drugs Product
Table 153. Zydus Cadila Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 154. Zydus Cadila Recent Development
Table 155. Hikma Company Details
Table 156. Hikma Business Overview
Table 157. Hikma Generic Drugs Product
Table 158. Hikma Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 159. Hikma Recent Development
Table 160. Pharmaniaga Berhad Company Details
Table 161. Pharmaniaga Berhad Business Overview
Table 162. Pharmaniaga Berhad Generic Drugs Product
Table 163. Pharmaniaga Berhad Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 164. Pharmaniaga Berhad Recent Development
Table 165. Hovid Berhad Company Details
Table 166. Hovid Berhad Business Overview
Table 167. Hovid Berhad Generic Drugs Product
Table 168. Hovid Berhad Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 169. Hovid Berhad Recent Development
Table 170. Duopharma Biotech Company Details
Table 171. Duopharma Biotech Business Overview
Table 172. Duopharma Biotech Generic Drugs Product
Table 173. Duopharma Biotech Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 174. Duopharma Biotech Recent Development
Table 175. Kotra Pharma Company Details
Table 176. Kotra Pharma Business Overview
Table 177. Kotra Pharma Generic DrugsProduct
Table 178. Kotra Pharma Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 179. Kotra Pharma Recent Development
Table 180. HOE Pharmaceutical Company Details
Table 181. HOE Pharmaceutical Business Overview
Table 182. HOE Pharmaceutical Generic Drugs Product
Table 183. HOE Pharmaceutical Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 184. HOE Pharmaceutical Recent Development
Table 185. Y.S.P. Industries Company Details
Table 186. Y.S.P. Industries Business Overview
Table 187. Y.S.P. Industries Generic Drugs Product
Table 188. Y.S.P. Industries Revenue in Generic Drugs Business (2016-2021) & (US$ Million)
Table 189. Y.S.P. Industries Recent Development
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Prescription Features
Figure 3. Non-Prescription Drugs Features
Figure 4. Global Generic Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Generic Drugs Report Years Considered
Figure 9. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Generic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Generic Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Generic Drugs Market Share by Regions (2022-2027)
Figure 13. Global Generic Drugs Market Share by Players in 2020
Figure 14. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2020
Figure 16. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Generic Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Generic Drugs Market Share by Type (2016-2027)
Figure 20. North America Generic Drugs Market Share by Application (2016-2027)
Figure 21. North America Generic Drugs Market Share by Country (2016-2027)
Figure 22. United States Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Generic Drugs Market Share by Type (2016-2027)
Figure 26. Europe Generic Drugs Market Share by Application (2016-2027)
Figure 27. Europe Generic Drugs Market Share by Country (2016-2027)
Figure 28. Germany Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Generic Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Generic Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Generic Drugs Market Share by Region (2016-2027)
Figure 38. China Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Generic Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Generic Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Generic Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Generic Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Generic Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Generic Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Generic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Teva Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 58. Novartis - Sandoz Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 59. Mylan Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 60. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 61. Aspen Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 62. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 63. Pfizer (Hospira) Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 65. Aurobindo Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 66. Lupin Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 67. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 68. Apotex Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 69. Cipla Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 70. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 71. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 72. Krka Group Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 73. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 74. Valeant Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 75. Zydus Cadila Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 76. Hikma Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 77. Pharmaniaga Berhad Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 78. Hovid Berhad Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 79. Duopharma Biotech Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 80. Kotra Pharma Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 81. HOE Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 82. Y.S.P. Industries Revenue Growth Rate in Generic Drugs Business (2016-2021)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Industry Market Size
